达巴万星

Dalbavancin

Abstract

No information is available on the use of dalbavancin during breastfeeding. Dalbavancin is 93% plasma protein bound and is poorly absorbed orally, so it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. If dalbavancin is required by the mother, it is not a reason to discontinue breastfeeding. Monitor the infant for possible effects on the gastrointestinal tract, such as diarrhea, vomiting, and candidiasis (e.g., thrush, diaper rash).

摘要

关于哺乳期使用达巴万星的信息尚无可用资料。达巴万星与血浆蛋白的结合率为93%，口服吸收差，因此不太可能进入婴儿的血液循环或对母乳喂养的婴儿造成任何不良影响。如果母亲需要使用达巴万星，这并不是停止母乳喂养的理由。监测婴儿是否有胃肠道方面的可能影响，如腹泻、呕吐和念珠菌病（如鹅口疮、尿布疹）。